Global Cold Pain Therapy Market is estimated to reach $1,185 Million by 2024; growing at a CAGR of 4.6% from 2016 to 2024. The cold pain therapy comprises the usage of cold ingredients in pain relief. It slows down blood flow to the injury which reduces pain & swelling with decrease in muscle spasm, inflammation and cold pain. Cold pain therapy is generally applied on the fresh injuries such as muscle sprains, ligament sprains and severe bruises. It is also helpful for chronic overuse or tissue fatigue injuries like tennis elbow, carpel tunnel syndrome, iliotibial band syndrome, supraspinatus tendinitis, plantar fasciitis, patellofemoral pain syndrome, and others.
Rising emphasis on exercise & gym activities in order to maintain health, global growth in occurrences of injuries during sport activities, and increase in consumer awareness due to advertising adopted by players are some of the major factors driving the global cold pain therapy market. However, substantial clinical evidences in favor of cold pain therapy, and side-effects and discomfort associated with cold pain therapy treatment may restrict the market growth. Though, increasing healthcare expenditure and stringent regulatory approval for oral pain medicines are likely to gain significant impetus for the market over the forthcoming years.
The cold pain therapy market is mainly classified into product, application, and geography. The classification by product primarily includes OTC based products and prescription based products. Where, OTC based products is further categorized into pharmaceuticals (gels, ointments, & creams, sprays & foams, patches, and roll-ons) and medical devices (cooling towels, compresses, wraps, & pads, and cold packs). And prescription based products is further categorized into motorized devices and non-motorized devices. The classification by application includes musculoskeletal disorder, sport medicine, post-operative, post-trauma, and physical therapy.
Based on geographical analysis, cold pain therapy market is classified into North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America is further bifurcated in U.S., Canada, and Mexico whereas Europe consist of UK, Russia, Germany, France, Italy, and others. Asia-Pacific is segmented into India, China, Japan, South Korea, and others while RoW is bifurcated into South America, Middle East, and Africa.
The key market players in the cold pain therapy market include Hisamitsu Pharmaceutical Co., Inc., 3M Company, Breg Inc., Johnson & Johnson, Ossur hf, ROHTO Pharmaceutical Co., Ltd., Sanofi, DJO Finance LLC, Beiersdorf AG, and Medline Industries Inc., among others.
The key takeaways from the report:
The report will provide detailed analysis of Cold Pain Therapy Market with respect to major segments such as product and application
The report will include the qualitative and quantitative analysis with market estimation over 2015-2024 and compound annual growth rate (CAGR) between 2016 and 2024
Comprehensive analysis of market dynamics including factors and opportunities will be provided in the report
An exhaustive regional analysis of Cold Pain Therapy Market has been included in the report
Profile of the key players in the Cold Pain Therapy Market will be provided, which include key financials, product & services, new developments and business strategies
Scope of Cold Pain Therapy Market:
Gels, Ointments, and Creams
Sprays and Foams
Cooling Towels, Compresses, Wraps, and Pads
Prescription Based Products